Evolva launches valencene

Guía de Regalos

REINACH, Switzerland–(BUSINESS WIRE)–Evolva (SIX:EVE) announces the launch of valencene, a highly
prized orange flavour and fragrance (F&F) ingredient. As an alternative
to extracting it from the skin of oranges, Evolva’s process allows
valencene to be made in large amounts in a highly reproducible,
contaminant free, sustainable and affordable manner. Evolva has
developed a cost efficient manufacturing process at large production
scale for valencene and we will start shipping initial commercial
samples to prospective clients in January.


“Valencene is a great addition to our growing product portfolio, nicely
complementing the nootkatone franchise” Evolva CEO Neil Goldsmith
said. “It is also a good example of our business strategy, focusing on
products with supply chain issues. As we concentrate on our core
pathways, we are generating substantial synergies in terms of R&D,
production as well as marketing.”

– ends-

About valencene

Valencene is an orange flavour and fragrance ingredient used in food and
beverage, personal care and household products, as well as an
intermediate to produce nootkatone. Traditional methods of producing
valencene require its extraction from the peel of oranges, meaning cost,
supply and quality fluctuate depending on the harvest. Furthermore, the
process is inefficient as it takes over 1 million kilograms of oranges
to obtain 1 kilogram of valencene.

About Evolva

Evolva is a pioneer and global leader in sustainable, fermentation-based
approaches to ingredients for health, wellness and nutrition. Evolva’s
products include stevia, resveratrol, vanillin, nootkatone and
saffron. As well as developing its own proprietary ingredients, Evolva
also deploys its technology for partners, providing them with a
competitive edge and sharing in the returns they make. For more
information see www.evolva.com.
Questions about our fermentation approach? Have a look at our video.

This press release contains specific forward-looking statements, e.g.
statements including terms like believe, assume, expect or similar
expressions. Such forward-looking statements are subject to known and
unknown risks, uncertainties and other factors which may result in a
substantial divergence between the actual results, financial situation,
development or performance of the company and those explicitly or
implicitly presumed in these statements. Against the background of these
uncertainties readers should not place undue reliance on forward-looking
statements. The company assumes no responsibility to update
forward-looking statements or to adapt them to future events or
developments.

Contacts

Evolva
Neil Goldsmith, CEO
neilg@evolva.com
+
41-61-485-2005
or
Jakob Dynnes Hansen, CFO
jakobdh@evolva.com
+
41-61-485-2034
or
Paul Verbraeken, IR
paulv@evolva.com
+
41-61-485-2035
or
Commercial enquiries
val@evolva.com
North
America
+ 1-800-250-1032
Rest of world
+ 41-61-485-2099